2012-10-06 19:28:03 - New Pharmaceuticals market report from Global Markets Direct: "PharmaIN Corporation - Product Pipeline Review - 2012"

Global Market Direct's pharmaceuticals report, "PharmaIN Corporation - Product Pipeline Review - 2012" provides data on the PharmaIN Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, PharmaIN Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from PharmaIN Corporation and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* PharmaIN Corporation - Brief PharmaIN Corporation overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of PharmaIN Corporation human therapeutic

division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of PharmaIN Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the PharmaIN Corporation's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468651_pharmain_corporation_product_pipeline ..


Reasons to buy

* Evaluate PharmaIN Corporation's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of PharmaIN Corporation in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the PharmaIN Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with PharmaIN Corporation.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of PharmaIN Corporation and identify potential opportunities in those areas.

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
PharmaIN Corporation Snapshot
PharmaIN Corporation Overview
Key Information
Key Facts
PharmaIN Corporation - Research and Development Overview
Key Therapeutic Areas
PharmaIN Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
PharmaIN Corporation - Pipeline Products Glance
PharmaIN Corporation - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
PharmaIN Corporation - Drug Profiles
Peptide for Liver Cirrhosis
Product Description
Mechanism of Action
R&D Progress
PGC Anti-MRSA
Product Description
Mechanism of Action
R&D Progress
PGC Basal Insulin
Product Description
Mechanism of Action
R&D Progress
PGC EGF-Gastrin
Product Description
Mechanism of Action
R&D Progress
PGC GLP-1
Product Description
Mechanism of Action
R&D Progress
PGC-VIP
Product Description
Mechanism of Action
R&D Progress
PHIN-837
Product Description
Mechanism of Action
R&D Progress
PharmaIN Corporation - Pipeline Analysis
PharmaIN Corporation - Pipeline Products by Therapeutic Class
PharmaIN Corporation - Pipeline Products by Route of Administration
PharmaIN Corporation - Pipeline Products By Mechanism of Action
PharmaIN Corporation - Locations And Subsidiaries
Head Office
Financial Deals Landscape
PharmaIN Corporation, Deals Summary
PharmaIN Corporation, Pharmaceuticals & Healthcare, Deal Details
Partnerships
PharmaIN Enters Into An Agreement With Pacific Northwest Diabetes Research Institute
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
PharmaIN Corporation, Key Information
PharmaIN Corporation, Key Facts
PharmaIN Corporation - Pipeline by Indication, 2012
PharmaIN Corporation - Pipeline by Stage of Development, 2012
PharmaIN Corporation - Monotherapy Products in Pipeline, 2012
PharmaIN Corporation - Pre-Clinical, 2012
PharmaIN Corporation - Discovery, 2012
PharmaIN Corporation - Pipeline By Therapeutic Class, 2012
PharmaIN Corporation - Pipeline By Route of Administration, 2012
PharmaIN Corporation - Pipeline Products By Mechanism of Action, 2012
PharmaIN Corporation, Deals Summary
PharmaIN Enters Into An Agreement With Pacific Northwest Diabetes Research Institute

List of Figures
PharmaIN Corporation - Pipeline by Indication, 2012
PharmaIN Corporation - Pipeline by Stage of Development, 2012
PharmaIN Corporation - Monotherapy Products in Pipeline, 2012
PharmaIN Corporation - Pipeline By Therapeutic Class, 2012
PharmaIN Corporation - Pipeline By Route of Administration, 2012
PharmaIN Corporation - Pipeline Products By Mechanism of Action, 2012

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.